Chromosome 9p21 primary open-angle glaucoma susceptibility locus: A review

Clinical and Experimental Ophthalmology

Volumn 42, Issue 1, 2014, Pages 25-32

  Ng, Soo Khai ^a,b   Casson, Robert J ^a,b   Burdon, Kathryn P ^c   Craig, Jamie E ^c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

9p21; CDKN2A; CDKN2B; CDKN2B AS1.

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLIN DEPENDENT KINASE INHIBITOR 2B ANTISENSE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AUTOSOME; CHROMOSOME 9P21; DIAGNOSTIC PROCEDURE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; OPEN ANGLE GLAUCOMA; PARAMETERS; REVIEW; RISK ASSESSMENT; VERTICAL CUP DISC RATIO;

9P21; CDKN2A; CDKN2B; CDKN2B-AS1.;

CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; RISK FACTORS; RNA, LONG NONCODING;

EID: 84892511744     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12234     Document Type: Review

References (67)

1. Casson RJ, Chidlow G, Wood JP, Crowston JG, Goldberg I. Definition of glaucoma: clinical and experimental concepts. Clin Experiment Ophthalmol 2012; 40: 341-349.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267.
3. Klein BE, Klein R, Sponsel WE etal. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 1499-1504.
4. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991; 266: 369-374.
5. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study: prevalence of open angle glaucoma. Arch Ophthalmol 1994; 112: 821-829.
6. Friedman DS, Jampel HD, Muñoz B, West SK. The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study. Arch Ophthalmol 2006; 124: 1625-1630.
7. Iwase A, Suzuki Y, Araie M etal. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004; 111: 1641-1648.
8. Nemesure B, He Q, Mendell N etal. Inheritance of open-angle glaucoma in the Barbados family study. Am J Med Genet 2001; 103: 36-43.
9. Gottfredsdottir MS, Sverrisson T, Musch DC, Stefansson E. Chronic open-angle glaucoma and associated ophthalmic findings in monozygotic twins and their spouses in Iceland. J Glaucoma 1999; 8: 134-139.
10. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol 2007; 125: 30-37.
11. Stone EM, Fingert JH, Alward WM etal. Identification of a gene that causes primary open angle glaucoma. Science 1997; 275: 668-670.
12. Rezaie T, Child A, Hitchings R etal. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002; 295: 1077-1079.
13. Monemi S, Spaeth G, DaSilva A etal. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005; 14: 725-773.
14. Allingham RR, Liu Y, Rhee DJ. The genetics of primary open angle glaucoma: a review. Exp Eye Res 2009; 88: 837-844.
15. Morton S, Hesson L, Peggie M, Cohen P. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett 2008; 582: 997-1002.
16. Fingert JH. Primary open-angle glaucoma genes. Eye 2011; 25: 587-595.
17. Hewitt AW, Craig JE, Mackey DA. Complex genetics of complex traits: the case of primary open-angle glaucoma. Clin Experiment Ophthalmol 2006; 34: 472-484.
18. Fan BJ, Wang DY, Pasquale LR, Haines JL, Wiggs JL. Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population. Invest Ophthalmol Vis Sci 2011; 52: 1788-1792.
19. Charlesworth J, Kramer PL, Dyer T etal. The path to open-angle glaucoma gene discovery: endophenotypic status of intraocular pressure, cup-to-disc ratio, and central corneal thickness. Invest Ophthalmol Vis Sci 2010; 51: 3509-3514.
20. Burdon KP, Macgregor S, Hewitt AW etal. Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet 2011; 43: 574-578.
21. Thorleifsson G, Walters GB, Hewitt AW etal. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet 2010; 42: 906-909.
22. Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med 2009; 360: 1113-1124.
23. European Glaucoma Prevention Study (EGPS) Group, Miglior S, Pfeiffer N etal. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 2007; 114: 3-9.
24. Bellezza AJ, Hart RT, Burgoyne CF. The optic nerve head as a biomechanical structure: initial finite element modeling. Invest Ophthalmol Vis Sci 2000; 41: 2991-3000.
25. Keltner JL, Johnson CA, Anderson DR etal. The association between glaucomatous visual fields and optic nerve head features in the ocular hypertension treatment study. Ophthalmology 2006; 113: 1603-1612.
26. Klein BE, Klein R, Lee KE. Heritability of risk factors for primary open angle glaucoma: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 2004; 45: 59-62.
27. van Koolwijk LM, Despriet DD, van Duijn CM etal. Genetic contributions to glaucoma: heritability of intraocular pressure, retinal nerve fiber layer thickness, and optic disc morphology. Invest Ophthalmol Vis Sci 2007; 48: 3669-3676.
28. Chang TC, Congdon NG, Wojciechowski R etal. Determinants and heritability of intraocular pressure and cup-to-disc ratio in a defined older population. Ophthalmology 2005; 112: 1186-1191.
29. Schwartz JT, Reuling FH, Feinleib M. Size of the physiologic cup of the optic nerve head: hereditary and environmental factors. Arch Ophthalmol 1975; 93: 776-778.
30. Ramdas WD, van Koolwijk LM, Ikram MK etal. A genome-wide association study of optic disc parameters. Plos Genet 2010; 6: e1000978.
31. Macgregor S, Hewitt AW, Hysi PG etal. Genome-wide association identifies ATOH7 as a major gene determining human optic disc size. Hum Mol Genet 2010; 19: 2716-2724.
32. Burdon KP, Crawford A, Casson RJ etal. Glaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucoma. Ophthalmology 2012; 119: 1539-1545.
33. Ramdas WD, van Koolwijk LM, Lemij HG etal. Common genetic variants associated with open-angle glaucoma. Hum Mol Genet 2011; 20: 2464-2471.
34. Wiggs JL, Yaspan BL, Hauser MA etal. Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet 2012; 8: e1002654.
35. Cao D, Jiao X, Liu X etal. CDKN2B polymorphism is associated with primary open-angle glaucoma (POAG) in the Afro-Caribbean population of Barbados, West Indies. PLoS ONE 2012; 7: e39278.
36. Osman W, Low SK, Takahashi A, Kubo M, Nakamura Y. A genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma. Hum Mol Genet 2012; 21: 2836-2842.
37. Nakano M, Ikeda Y, Tokuda Y etal. Common variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in Japanese. PLoS ONE 2012; 7: e33389.
38. Takamoto M, Kaburaki T, Mabuchi A etal. Common variants on chromosome 9p21 are associated with normal tension glaucoma. PLoS ONE 2012; 7: e40107.
39. Greene LA, Liu DX, Troy CM, Biswas SC. Cell cycle molecules define a pathway required for neuron death in development and disease. Biochim Biophys Acta 2007; 1772: 392-401.
40. Canepa ET, Scassa ME, Ceruti JM etal. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 2007; 59: 419-426.
41. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta induced cell cycle arrest. Nature 1994; 371: 257-261.
42. Kim WY, Sharpless NE. The regulation of INK4/ARF in cancer and aging. Cell 2006; 127: 265-275.
43. Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia lymphoma cells. Leukemia 1998; 12: 845-859.
44. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006; 7: 667-677.
45. Pasmant E, Sabbagh A, Vidaud M, Bièche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011; 25: 444-448.
46. Helgadottir A, Thorleifsson G, Manolescu A etal. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316: 1491-1493.
47. Scott LJ, Mohlke KL, Bonnycastle LL etal. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316: 1341-1345.
48. Bilguvar K, Yasuno K, Niemelä M etal. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 2008; 40: 1472-1477.
49. Shete S, Hosking FJ, Robertson LB etal. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009; 41: 899-904.
50. Jarinova O, Stewart AF, Roberts R etal. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 2009; 29: 1671-1677.
51. Harismendy O, Notani D, Song X etal. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signaling response. Nature 2011; 470: 264-268.
52. Fuchshofer R. The pathogenic role of transforming growth factor-beta2 in glaucomatous damage to the optic nerve head. Exp Eye Res 2011; 93: 165-169.
53. Kirwan RP, Leonard MO, Murphy M, Clark AF, O'Brien CJ. Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells. Glia 2005; 52: 309-324.
54. Han H, Wecker T, Grehn F, Schlunck G. Elasticity-dependent modulation of TGF-{beta} responses in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2011; 52: 2889-2896.
55. Massagué J, Blain SW, Lo RS. TGF-beta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.
56. Pasquale LR, Dorman-Pease ME, Lutty GA, Quigley HA, Jampel HD. Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 1993; 34: 23-30.
57. Pena JD, Taylor AW, Ricard CS, Vidal I, Hernandez MR. Transforming growth factor beta isoforms in human optic nerve heads. Br J Ophthalmol 1999; 83: 209-218.
58. Pfeffer BA, Flanders KC, Guerin CJ, Danielpour D, Anderson DH. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res 1994; 59: 323-333.
59. Fukuchi T, Ueda J, Hanyu T, Abe H, Sawaguchi S. Distribution and expression of transforming growth factor-beta and platelet derived growth factor in the normal and glaucomatous monkey optic nerve heads. Jpn J Ophthalmol 2001; 45: 592-599.
60. Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 2001; 239: 199-207.
61. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 1994; 59: 723-727.
62. Wordinger RJ, Clark AF, Agarwal R etal. Cultured human trabecularmeshwork cells express functional growth factor receptors. Invest Ophthalmol Vis Sci 1998; 39: 1575-1589.
63. Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH, Clark AF. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci 2006; 47: 226-234.
64. Fuchshofer R, Tamm ER. Modulation of extracellular matrix turnover in the trabecular meshwork. Exp Eye Res 2009; 88: 683-688.
65. Sethi A, Mao W, Wordinger RJ, Clark AF. Transforming growth factor beta induces extracellular matrix protein crosslinking lysyl oxidase (LOX) genes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2011; 52: 5240-5250.
66. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massagué J. TGF-beta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 2001; 3: 400-408.
67. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487-497.